1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Trulieve Cannabis Corp.
  6. Financials
    TCNNF   CA89788C1041

TRULIEVE CANNABIS CORP.

(TCNNF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 1 3053 7744 7762 657--
Enterprise Value (EV)2 1 3463 7274 7633 0893 0252 953
P/E ratio 7,68x59,5x217x-281x47,3x29,2x
Yield ------
Capitalization / Revenue 5,16x7,24x5,09x1,94x1,50x1,64x
EV / Revenue 5,32x7,15x5,08x2,25x1,71x1,83x
EV / EBITDA 10,2x14,9x12,4x6,48x4,22x5,14x
Price to Book 4,83x8,34x1,78x1,21x1,21x1,11x
Nbr of stocks (in thousands) 110 346119 579183 507199 047--
Reference price (USD) 11,831,626,013,313,313,3
Announcement Date 04/08/202003/23/202103/30/2022---
1 CAD in Million
2 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 2535229381 3701 7661 616
EBITDA1 133251385477717575
Operating profit (EBIT)1 124227337270349378
Operating Margin 49,1%43,5%35,9%19,7%19,8%23,4%
Pre-Tax Profit (EBT)1 272157164166276320
Net income1 17863,018,0-20,645,884,7
Net margin 70,4%12,1%1,92%-1,51%2,59%5,24%
EPS2 1,540,530,12-0,050,280,46
Dividend per Share ------
Announcement Date 04/08/202003/23/202103/30/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 224305318319343390
EBITDA1 98,0101106106120145
Operating profit (EBIT)1 90,372,676,263,975,683,7
Operating Margin 40,3%23,8%23,9%20,0%22,0%21,5%
Pre-Tax Profit (EBT)1 60,2-31,39,8341,752,559,0
Net income1 18,6-71,5-32,0-3,933,3112,1
Net margin 8,31%-23,4%-10,1%-1,23%0,96%3,11%
EPS2 0,14-0,56-0,17-0,010,030,07
Dividend per Share ------
Announcement Date 11/15/202103/30/202205/12/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 41,4--432368296
Net Cash position1 -46,713,8---
Leverage (Debt / EBITDA) 0,31x-0,19x-0,04x0,90x0,51x0,51x
Free Cash Flow1 -51,2-46,2-263-65,548,7122
ROE (Net Profit / Equities) 92,1%21,7%9,52%1,88%4,12%2,40%
Shareholders' equity1 193290189-1 1011 1113 531
ROA (Net Profit / Asset) 47,3%10,5%21,4%1,00%2,98%1,40%
Assets1 37660184,0-2 0651 5386 053
Book Value Per Share2 2,453,7914,611,011,012,0
Cash Flow per Share2 0,200,840,080,780,32-
Capex1 74,799,9276222155104
Capex / Sales 29,5%19,2%29,4%16,2%8,75%6,43%
Announcement Date 04/08/202003/23/202103/30/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (CAD) 3 423 616 552
Capitalization (USD) 2 657 262 148
Net sales (USD) 938 400 000
Number of employees 9 000
Sales / Employee (USD) 104 267
Free-Float 65,7%
Free-Float capitalization (CAD) 2 248 086 099
Free-Float capitalization (USD) 1 744 866 578
Avg. Exchange 20 sessions (USD) 3 430 786
Average Daily Capital Traded 0,10%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA